American Century Companies’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
BIP
American Century Companies's TAK Position: Q2 2026 in Review
American Century Companies increased its Takeda Pharmaceutical (TAK) stake by 13% in Q2 2026, buying an estimated $1.15M and bringing the position to 584,560 shares worth $9.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1595.
American Century Companies first reported a position in TAK in Q1 2020 and has held it in 26 quarters since. The position peaked at $21.5M in Q3 2022. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.
- American Century Companies held 584,560 shares of Takeda Pharmaceutical worth $9.37M as of Q2 2026.
- American Century Companies bought 69,201 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.15M.
- Takeda Pharmaceutical made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1595 holding.
- American Century Companies first reported a position in Takeda Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
- American Century Companies's Takeda Pharmaceutical position peaked at $21.5M in Q3 2022.
- 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.